ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
3.920
-0.180 (-4.39%)
Apr 1, 2025, 7:13 PM EDT - Market open

ENDRA Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2318132925
Upgrade
Market Cap Growth
-81.25%-81.25%39.49%-55.93%15.68%100.27%
Upgrade
Enterprise Value
-1-11561822
Upgrade
Last Close Price
3.926.263710.007122.5124213.0226250.03
Upgrade
PB Ratio
0.821.313.171.782.703.52
Upgrade
P/TBV Ratio
1.311.313.171.782.703.52
Upgrade
Debt / Equity Ratio
0.230.230.100.100.070.11
Upgrade
Quick Ratio
5.345.343.142.876.137.33
Upgrade
Current Ratio
5.675.673.363.167.838.32
Upgrade
Return on Equity (ROE)
-280.02%-280.02%-156.42%-146.53%-125.11%-196.57%
Upgrade
Return on Assets (ROA)
-120.66%-120.66%-82.05%-74.26%-66.42%-90.19%
Upgrade
Return on Capital (ROIC)
-144.66%-144.66%-93.19%-84.39%-73.63%-107.05%
Upgrade
Earnings Yield
-546.78%-342.39%-56.13%-102.57%-38.53%-46.53%
Upgrade
FCF Yield
--53.47%-100.96%-38.31%-42.94%
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q